According to World Health Organization (WHO), Health is "a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity”.
Mental Health is not just the absence of mental illness but "a state of well-being in which the individual realizes his or her own abilities, can cope with the normal stresses of life, can work productively and fruitfully, and is able to make a contribution to his or her community".
We have a team of professionals including Psychologists and Psychiatrists who deliver effective, safe and evidence based mental health services. We also actively collaborate with General Practitioners and medical specialists to achieve a state of well-being for our patients.
MBBS, FRANZCP, Cert. Adult.Psych.
Consultant Psychiatrist
MBBS, DPM, FRANZCP.
Consultant Psychiatrist
BA, PstDip Psych, M.Clinic, Psych
Clinical Psychologist
B. Psych, PGDipPsych, MPsych, MCrim
Registered Psychologist
BA, BPsychSt(Hons), MProfPsych, MPsych(Clinical), MAPS
Registered Psychologist
Depression
Schizophrenia and other Psychotic Disorders
Anxiety Disorders – Panic, OCD and Phobias
Acute Stress, Post Traumatic Stress Disorders
Perinatal Mental Health
Personality Disorders Including Borderline Personality Disorders
DBT- Dialectical Behavior Therapy
Grief, Loss and Separation
Eating Disorders
Trauma
Anger Management
Addictions
Psychiatry
Psychology
Repetitive Transcranial Magnetic Stimulation (rTMS) is a non-invasive treatment that uses targeted magnetic pulses to stimulate areas of the brain involved in mood regulation. It’s commonly used for people with major depression who haven’t responded to medication or therapy. rTMS doesn’t require surgery or anesthesia, is generally well tolerated, and is delivered over a series of sessions to help improve mood and reduce symptoms. We have been delivering rTMS therapy since 2023.
Contact Us ► | Learn More ►
SPRAVATO contains esketamine hydrochloride, a form of ketamine with a novel mechanism of action. It is used together with a newly started oral antidepressant for adults with treatment‑resistant depression. We have been delivering Esketamine therapy since 2022.
